NewsRx

Search our medical news database

Drug Development

Acologix presents preclinical data on synthetic peptide

Published in Drug Week, June 16th, 2006

Acologix, Inc., announced that a preclinical study describing the mechanism of action of its novel synthetic peptide, AC-100 was presented at the 33rd annual meeting of the European Calcified Tissue Society (ECTS) in Prague, Czech Republic.

AC-100 is a synthetic peptide derived from an endogenous human protein produced primarily by bone and dental cells and has previously been shown to specifically promote new dentin formation in teeth and bone formation at fracture and healing sites with no ectopic calcification. The data were presented by Catherine Middleton-Hardie of Acologix who was given a Young Investigator's Award for the submitted abstract.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook